BCL2 and neoplasm: In our study, bcl-2 scoring was done taking into consideration the number (percentage) of positive cells in the tumor parenchyma as described by Xie et al. In study done by Xie et al., bcl-2 immunoreactivity was found in 83(97%) out of 85 cases [10].